The Epstein–Barr Virus Latent Membrane Protein 1 Induces Interleukin-10 in Burkitt's Lymphoma Cells but Not in Hodgkin's Cells Involving the p38/SAPK2 Pathway

This publication has 58 references indexed in Scilit:

• The AT-rich region between −54 to −66 is important for the promoter activity of interleukin-10 in Epstein–Barr virus positive Burkitt’s lymphoma cells
  Genes & Immunity, 1999
• Epstein–Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions
  Oncogene, 1998
• THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE
  Annual Review of Immunology, 1998
• Epstein – Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors
  Oncogene, 1997
• Normal and malignant B-cell development with special reference to Hodgkin's disease
  Annals of Oncology, 1997
• The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
  Cell, 1995
• Prognostic value of serum IL‐10 and soluble IL‐2 receptor levels in aggressive non‐Hodgkin's lymphoma
  British Journal of Haematology, 1994
• Interleukin-10
  Annual Review of Immunology, 1993
• Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10.
  The Journal of Experimental Medicine, 1993
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991